Novartis Shakes Suit Over Bone Drug Warnings

Law360, New York (November 1, 2011, 1:18 PM EDT) -- Novartis Pharmaceuticals Corp. on Monday won summary judgment in a Georgia suit remanded from multidistrict litigation claiming the company failed to warn that its bone drugs Aredia and Zometa were linked to bone death in the jaw.

Novartis has so far scored victories in two trials stemming from state or federal consolidated products liability litigation over Aredia and Zometa. The company is hoping for a retrial in a third case in which a jury initially told Novartis to pay $12.8 million to the plaintiff, but a...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Eberhart v. Novartis Pharmaceuticals Corporation


Case Number

1:08-cv-02542

Court

Georgia Northern

Nature of Suit

Personal Inj. Prod. Liability

Judge

William S. Duffey, Jr

Date Filed

August 7, 2008

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.